肝癌细胞HepG2中p53调控miRNA-3661的生物信息分析与功能验证

doi:10.13560/j.cnki.biotech.bull.1985.20170005

摘要/Abstract

摘要： 对已在前期实验中通过Dox诱导肝癌细胞HepG2 DNA损伤发现的受p53调控的hsa-miR-3661进行生物信息学分析，并通过分子生物学实验对其功能进行了验证，为miR-3661在肝肿瘤中的调控机制的研究提供理论基础。获取miR-3661结构与序列信息；预测靶基因，使用DAVID进行miRNA靶基因功能富集分析；分析miR-3661的p53结合位点，通过基因间的相互作用构建调控网络；进行细胞增殖实验验证miR-3661抑制肿瘤功能。结果表明，miR-3661序列保守，启动子区存在p53结合位点，暗示p53与hsa-miR-3661存在直接调控；预测靶基因1 009个，369个显著富集于细胞周期调控、细胞增殖、细胞凋亡等肿瘤相关生物学过程（P<0.05），主要参与了癌症信号通路、MAPK信号通路与ErbB信号通路（P<0.05）；通过268组基因间的相互作用数据构建了p53、hsa-miR-3661和靶基因的调控网络，从系统生物学角度分析了参与多个肿瘤生物进程的关键靶基因；在实验中证实过表达miR-3661可以显著抑制肝癌细胞HepG2的增殖过程（P-value= 0.001 46）。miR-3661受p53直接调控，其靶基因显著富集于多种肿瘤相关生物进程与信号通路，过表达miR-3661可显著抑制肝癌细胞增殖。

关键词: 肝细胞癌, microRNAs, 生物信息学, 阿霉素

Abstract: The aims of this work are to have the bioinformatics analysis of hsa-miR-3661 regulated by p53，which was found in doxorubicin（Dox）inducing the DNA damages of hepatoma cell HepG2 in previous experiment，and to verify its function by molecular biological experiment，providing theoretical basis for the regulating mechanism of miR-3661 in hepatoma cells. After acquiring the structure and sequence information of miR-3661，we predicted the target genes and used DAVID to do the functional enrichment analysis of miRNA target gene. We then analyzed the binding sites of p53 and miR-3661，and built the regulatory network by the interaction among genes. Finally，multiplication experiment verified the functions of miR-3661 in restraining tumor. The results showed that miR-3661 sequence was conserved，and the promoter region existed in the binding site of p53，suggesting that there was direct regulation between p53 and hsa-miR-3661. We predicted that there were 1009 target genes，and 369 genes of them significantly enriched in the biological procedure related to tumor，such as cell cycle regulation，proliferation，apoptosis and so on（P < 0.05），mainly involved in cancer pathway，MAPK signaling pathway，ErbB signaling pathway（P < 0.05）. Using the interactions of 2830 groups of genes，we constructed the regulatory network among p53，hsa-miR-3661 and target genes，and analyzed key target gene participating in several tumorous biological process from the perspective of system biology. It was confirmed in the experiment that the overexpression of miR-3661 significantly inhibited the proliferation of hepatoma cell HepG2 （P-value= 0.00146）. In conclusion，miR-3661 is directly regulated by p53 and its target genes significantly enrich in various biological processes and signal pathways related to tumor. Moreover，the overexpression of miR-3661 significantly inhibits the proliferation of hepatoma cell.

Key words: hepatocellular carcinoma, microRNAs, bioinformatics, doxorubicin

李宇鹏,张一鸣,胡海碧,康成宇,李牧洲,郭志云. 肝癌细胞HepG2中p53调控miRNA-3661的生物信息分析与功能验证[J]. 生物技术通报, 2017, 33(7): 216-223.

LI Yu-peng ,ZHANG Yi-ming,HU Hai-bi ,KANG Cheng-yu, LI Mu-zhou ,GUO Zhi-yun. Bioinformatics Analysis and Functional Verification of p53 Regulating miRNA-3661 in Hepatoma Cell HepG2[J]. Biotechnology Bulletin, 2017, 33(7): 216-223.

参考文献

[1] Yang JD, Roberts LR. Epidemiology and management of hepatocellular carcinoma[J] . Infectious Disease Clinics of North America, 2010, 24（4）：899-919.
[2] Liu J, Zhang C, Feng Z. Tumor suppressor p53 and its gain-of-function mutants in cancer[J] . Acta Biochimica et Biophysica Sinica, 2014, 46（3）：170-179.
[3] Yang Y, Liu W, Ding R, et al. Comprehensive expression profiling and functional network analysis of p53-regulated MicroRNAs in HepG2 Cells treated with doxorubicin[J] . PLoS One, 2016, 11（2）：e0149227.
[4] Agarwal V, Bell GW, Nam JW, Bartell DP. Predicting effective microRNA target sites in mammalian mRNAs[J] . Elife, 2015, 4：e05005.
[5] Chatr-Aryamontri A, Breitkreutz BJ, Oughtred R, et al. The BioGRID interaction database：2015 update[J] . Nucleic Acids Res, 2015, 43（Database issue）：D470-478.
[6] Betel D, Koppal A, Agius P, et al. Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites[J] . Genome Biology, 2010, 11（8）：R90.
[7] Huang DW, Sherman BT, Lempicki RA. Bioinformatics enrichment tools：paths toward the comprehensive functional analysis of large gene lists[J] . Nucleic Acids Research, 2009, 37（1）：1-13.
[8] Vlachos IS, Paraskevopoulou MD, Karagkouni D, et al. DIANA-TarBase v7. 0：indexing more than half a million experimentally supported miRNA：mRNA interactions[J] . Nucleic Acids Research, 2015, 43（D1）：D153-D159.
[9] Zeron-Medina J, Wang X, Repapi E, et al. A polymorphic p53 response element in KIT ligand influences cancer risk and hsa undergone natural selection[J] . Cell, 2013, 155（2）：410-422.
[10] Shannon P, Markiel A, Ozier O, et al. Cytoscape：a software environment for integrated models of biomolecular interaction networks[J] . Genome Research, 2003, 13（11）：2498-2504.
[11] Park SJ, Yang SW, Kim BC. Transforming growth factor-beta1 induces cell cycle arrest by activating atypical cyclin-dependent kinase 5 through up-regulation of Smad3-dependent p35 expression in human MCF10A mammary epithelial cells[J] . Biochem Biophys Res Commun, 2016, 472（3）：502-507.
[12] Pal SK, Nguyen CT, Morita KI, et al. THBS1 is induced by TGFB1 in the cancer stroma and promotes invasion of oral squamous cell carcinoma[J] . J Oral Pathol Med, 2016, 45（10）：730-739.
[13] Kim W, Kim E, Lee S, et al. TFAP2C-mediated upregulation of TGFBR1 promotes lung tumorigenesis and epithelial-mesenchymal transition[J] . Exp Mol Med, 2016, 48（11）：e273.
[14] D’Annibale S, Kim J, Magliozzi R, et al. Proteasome-dependent degradation of transcription factor activating enhancer-binding protein 4（TFAP4）controls mitotic division[J] . J Biol Chem, 2014, 289（11）：7730-7737.
[15] Palaniappan A, Ramar K, Ramalingam S. Computational identification of novel stage-specific biomarkers in colorectal cancer progression[J] . PLoS One, 2016, 11（5）：e0156665.
[16] Pe?ina-?laus N, Kafka A, Vladu?i? T, et al. AXIN1 expression and localization in meningiomas and association to changes of APC and e-cadherin[J] . Anticancer Res, 2016, 36（9）：4583-4594.
[17] Sethuraman A, Brown M, Seagroves TN, et al. SMARCE1 regulates metastatic potential of breast cancer cells through the HIF1A/PTK2 pathway[J] . Breast Cancer Res, 2016, 18（1）：81.
[18] Yasumoto M, Sakamoto E, Ogasawara S, et al. Muscle RAS oncogene homolog（MRAS）recurrent mutation in Borrmann type IV gastric cancer[J] . Cancer Med, 2017, 6（1）：235-244.
[19] Wu Y, Yun D, Zhao Y, et al. Down regulation of RNA binding motif, single-stranded interacting protein 3, along with up regulation of nuclear HIF1A correlates with poor prognosis in patients with gastric cancer[J] . Oncotarget, 2017, 8（1）：1262-1277.
[20] Singh P, Ravanan P, Talwar P. Death associated protein kinase 1（DAPK1）：a regulator of apoptosis and autophagy[J] . Front Mol Neurosci, 2016, 9：46.
[21] Piriyapongsa J, Jordan IK, Conley AB, et al. Transcription factor binding sites are highly enriched within microRNA precursor sequences[J] . Biology Direct, 2011, 6：61.
[22] Strietz J, Stepputtis SS, Precac BT, et al. ERN1 and ALPK1 inhibit differentiation of bi-potential tumor-initiating cells in human breast cancer[J] . Oncotarget, 2016, 7（50）：83278-83293.
[23] Guo H, Xu Y, Fu Q. Curcumin inhibits growth of prostate carcinoma via miR-208-mediated CDKN1A activation[J] . Tumor Biology, 2015, 36（11）：8511-8517.